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Patterns of prescription medication diversion among drug
dealers
Khary K. Rigg, Steven P. Kurtz, and Hilary L. Surratt
Center for Research on Substance Use and Health Disparities, Nova Southeastern University,
2121 Ponce de Leon Boulevard, Suite #430, Coral Gables, FL 33134, USA
Abstract
This research examined the following questions: (1) how do drug dealers acquire their inventories
of prescription medications? and (2) which types of prescription medications do dealers most
commonly sell? Data are drawn from a National Institute on Drug Abuse-funded research study
that examined prescription drug diversion and abuse in South Florida. In-depth semi-structured
interviews (n = 50) were conducted with an ethnically diverse sample of prescription drug dealers
from a variety of milieus to assess patterns of diversion. Audiotapes of the interviews were
transcribed, coded, and thematically analysed using the NVivo 8 software program. Dealers relied
on a wide array of diversion methods including visiting multiple pain clinics, working with
pharmacy employees to steal medications from pharmacies, and purchasing medications from
indigent patients. The type of medication most commonly sold by dealers was prescription opioid
analgesics, and to a lesser extent benzodiazepines such as alprazolam. These findings inform
public health policy makers, criminal justice officials, the pharmaceutical industry and
government regulatory agencies in their efforts to reduce the availability of diverted prescription
drugs in the illicit market. Specifically, these data support the need for statewide prescription drug
monitoring programs and increased training for healthcare workers who have access to controlled
medications.
INTRODUCTION
While prescription drug diversion is not a new problem, it has received increased attention
from policymakers and the research community due to an unprecedented rise in prescription
drug abuse. Diversion, which is defined as the transfer of a prescription drug from a lawful
to an unlawful channel of distribution or use, has been estimated by the Drug Enforcement
Administration to be a $25 billion a year industry (National Drug Safety Network, 1996; US
General Accounting Office, 2003), and yet it remains a phenomenon that in many respects is
poorly understood (Inciardi, Surratt, Kurtz, & Cicero, 2007). Researchers have had a
difficult time acquiring empirical data on certain aspects of the diversion system, partly due
to the plethora of players in the industry, including: physicians, pharmacists and other health
care professionals; drug dealers and abusers, patients, students, and white collar criminals;
tourists, night club owners and all types of service personnel (Inciardi, Surratt, Lugo, &
Cicero, 2007). In fact, the term ‘disorganized crime’ was coined precisely to describe the
abstruseness of the diversion problem (Inciardi, Surratt, Lugo, et al., 2007).
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More recently, diversion has been referred to as a ‘black box’ because of the lack of clarity
that exists on how the preponderance of prescription drugs make their way to the illicit
market and who the major diverters are (Inciardi et al., 2009b). The ‘disorganized crime’
and ‘black box’ monikers not only speak to the complexity of the diversion process, but also
to its hidden nature. These attributes have presented challenges to researchers attempting to
systematically examine the problem, and the result is an understanding of diversion with
numerous knowledge gaps. One of those gaps is the paucity of data on the activities of
prescription drug dealers/sellers, an aspect of the diversion system about which little is
known. Which prescription medications do street dealers typically sell, and more
importantly how do they acquire them? This study aims to answer these questions, and in so
doing fill an important void in the diversion literature.
Dealers are among the most frequently mentioned access points for diverted prescription
medications. A search of the literature revealed numerous studies that confirm the strong
presence of drug dealers across the diversion landscape. For example, previous research
studies examining drug use among methadone maintenance patients (Rosenblum et al.,
2007), active street drug users (Davis & Johnson, 2008; Inciardi, Surratt, Kurtz, et al., 2007),
drug treatment clients (Cicero et al., 2011), club drug users (Inciardi, Surratt, Kurtz, et al.,
2007) and commercial sex-workers (Surratt, Inciardi, & Kurtz, 2006) have all found dealers
to be an important source for prescription medications. Drug dealers are also a popular
source for prescription drugs among high school students. In fact, in a study that included
80% of all 11th graders in the state of Delaware, over 70% of the sample reported
purchasing controlled medications from street dealers (Inciardi et al., 2009b). A study
looking at students (age 10–18) in a Detroit area public school district also found that
dealers were among the most common sources of illegally obtained prescription drugs
(Boyd, McCabe, & Teter, 2006). Additionally, available data indicate that some college
students obtain prescription medications through dealers (McCabe, Cranford, Boyd, &
Teter, 2007; Srnick, 2007). And while dealers appear to be utilized to a lesser extent by the
general population, surveillance data from 2006 to 2009 show an upward trend in the
amount of prescription opioid abusers who reported dealers as a source for pain relievers
(SAMHSA, 2009).
Although data overwhelmingly point to dealers as important players in the world of
prescription drug diversion and a point of access for a wide range of drug using populations,
little is known about the methods through which dealers typically acquire their stocks of
medications (Inciardi & Cicero, 2009; Inciardi, Surratt, Cicero, & Beard, 2009a). On this
point, several diversion experts have recently called for further investigation into the role of
dealers in the overall diversion puzzle (Davis & Johnson, 2008; Inciardi & Cicero, 2009;
Inciardi, Surratt, Lugo, et al., 2007; Rosenblum et al., 2007), as this information may
establish a foundation for new initiatives aimed at reducing the illicit availability of
prescription drugs. Answers to the questions of where and how dealers obtain their supply of
prescription medications would not only inform criminal justice officials, but also public
health policy makers, the pharmaceutical industry and government regulatory agencies. By
focusing prevention/intervention efforts specifically at the diversion mechanisms of dealers,
this would facilitate the direction of scarce prevention resources towards the diversion
arteries that contribute most heavily to the illicit supply of prescription medications on the
black market. To this end, this study aims to address this critical knowledge gap by
examining the following research questions: (1) how do prescription drug dealers acquire
their inventories of prescription medications? and (2) which types of prescription
medications do dealers most commonly sell?
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METHODS
The data are drawn from a 4-year research study funded by the National Institute on Drug
Abuse. The study’s overarching goal is to examine and describe the complex mechanisms
and players that connect illicit supplies of prescription drugs to abusers in South Florida.
This study utilized a three-pronged approach to examine the diversion problem by collecting
data from prescription drug dealers, abusers and drug diversion investigators. In the
component of the study that targeted prescription drug dealers, the primary goal was to
obtain rich, detailed information on the dynamics of prescription drug diversion through
indepth interviews with individuals who are active distributors in the diversion market.
These participants represent the focus of this analysis.
South Florida
The study was conducted in South Florida (Miami-Dade, Broward, and Palm Beach
Counties), a prime location for investigating diversion. Recently, South Florida has received
attention from media outlets and lawmakers for being an active area for prescription drug
diversion, suggesting that the locale is appropriate for the study of this phenomenon
(LaForgia, 2009; LaMendola, 2009). Indeed, many law enforcement officials believe a great
deal of the prescription drugs being abused nationwide, especially in the northeast and
Appalachian states, can be traced back to South Florida, indicating that the data from this
study should have relevance for other parts of the country (Hiaasen, 2009). Finally, South
Florida is largely metropolitan and ethnically diverse, with 44.5% non-Hispanic whites,
33.6% Hispanics and 18.9% Blacks, which may serve to maximize the generalizability of
the findings to other urban areas in the USA (US Census Bureau, 2000).
Recruitment
A variety of recruitment techniques were used to locate active sellers of prescription drugs.
Some participants were selected from the survey component of the larger study that focused
on prescription drug abusers. Abusers who identified themselves as dealers or reported
selling a large quantity of prescription medications were referred to be screened for dealer
interviews. Additionally, the researchers were able to recruit some dealers through
previously established networks of key informants based on prior work in South Florida.
These informants were typically participants in other ongoing studies conducted by the
authors, or customers/associates of prescription drug dealers who agreed to make
recruitment contact on the researchers’ behalf. Informants essentially ‘vouched’ for the
research team and then had dealers call the study phone number to be screened. At no time
were informants asked to reveal identifying information about these dealers. We also
established recruitment partnerships with local drug treatment centres, whereby staff agreed
to refer clients with histories of prescription drug selling/abuse to the research team for
further screening. Finally, we used chain-referral as a recruitment tool, where each
participant who completed an interview was also invited to refer anyone they thought would
be eligible for the study. Participants were paid a $30 incentive for referring eligible
individuals who completed an interview.
Screening and eligibility criteria
All participants were screened for eligibility prior to being scheduled for the in-depth
interview. Interested individuals called the study phone number and were screened over the
phone. To be eligible for the study, individuals needed to be 18 years of age or older and
report selling at least 100 pills of prescription opioids, sedatives and/or stimulants within the
last 30 days. This cut-off point was chosen in an attempt to discriminate dealers from ‘users
who sell’. Eligibility was determined by their responses to a series of questions pertaining to
the types and quantities of prescription drugs they sold, the method in which the drugs were
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obtained, and their knowledge of street prices. If they were found eligible, prescription drug
sellers were scheduled for an interview. In some cases, prescription drug sellers were
identified by treatment staff upon conducting a brief screener of all new weekly admissions.
A brief screening tool helped identify clients with a history of prescription drug selling/
abuse. Someone from the treatment staff would then contact a member of the research team
to schedule an interview for the client at the treatment facility. Prescription drug sellers were
also selected for diversity across the following parameters: gender, race/ethnicity,
transaction volume, primary prescription drug sold and customer type. All study protocols
and instruments were reviewed and approved by the University of Delaware’s Institutional
Review Board (IRB).
Interview procedures
A total of 50 prescription drug sellers from diverse networks were interviewed between
September 2008 and August 2010. Interviews were conducted in private, at a research field
office or treatment centre. The interviewer used a standard interview guide to direct the
semi-structured interview. The interview guide included the following questions/prompts:
tell me about which prescription drugs you sell and why; how much do you buy/sell each
medication for; how do you obtain the medications that you sell; can you give me some
general information about the types of customers you have. Open-ended questions were
asked to allow for the emergence of unanticipated themes and to provide participants an
opportunity to be as detailed as possible in their explanation of their diversion behaviours.
Interviews typically lasted for 60 min. Upon completion of the in-depth interview,
participants were paid a $50 stipend for their participation. Each interview was recorded
using a digital voice recorder, but identity data were not included on the audio file. In an
effort to minimize risks to participants in the study, the University of Delaware’s IRB
approved a waiver of signed consent so as to maintain anonymity of participants.
Data analyses
All interviews were conducted and analysed by the first author. The digitally recorded
interviews were transcribed verbatim by a professional transcriber and subsequently
imported into NVivo 8, a qualitative data analysis computer software program. The use of
this software package’s search engine and query functions enhanced the ability to identify
trends, examine diversion patterns, and search for salient themes in the data. Although the
interview guide targeted several aspects of prescription drug selling, the analyses presented
here focus on: (1) identifying and describing the most important themes related to how
dealers obtained their inventories of prescription drugs and (2) determining which types of
medication that dealers most commonly sold. While the analysis was approached with an
awareness of the diversion literature, there were no a priori coding categories as themes
were allowed to emerge from the data. The coding categories were largely descriptive, and
reoccurring patterns within the data were identified in an inductive or ‘bottom up’ manner.
Thematic analysis was selected as the preferred method for analysing the interview
transcripts. This is a widely used method for identifying, analysing and reporting patterns
and themes within text data (Braun & Clarke, 2006). It was chosen because it is a flexible
technique that is relatively accessible and can be used to analyse data obtained under a
number of qualitative theoretical frameworks (Braun & Clarke, 2006; Douglas, Hamilton, &
Grubs, 2009). The use of thematic analysis is appropriate in cases such as this, where the
research topic is understudied and there are insufficient data in the literature to create a
coding scheme (Douglas et al., 2009). Additionally, the method is particularly useful when
the research question is broad in nature and the goal is to identify and richly describe the
important themes relating to a phenomenon of interest.
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Although, grounded theory and thematic analysis bear some resemblance in their analytic
frameworks, the manner in which themes, concepts and categories are managed vary
considerably (Braun & Clarke, 2006). As theory development was not a goal of this
research, grounded theory was not chosen to guide this investigation. Analysis was
theoretically informed by a subtle realist paradigm, which assumes that we can only
understand a phenomenon from our own perspective of it (Guba & Lincoln, 1994). Subtle
realists state that even though all research involves subjective perceptions and observations,
this subjectivity does not preclude the existence of independent phenomena (Hammersley,
1992; Kirk & Miller, 1986). Furthermore, the experiences and behaviours of individuals can
be studied by systematically examining the language that people use, which enable us to
reflect and articulate our experiences (Duncan & Nicol, 2004). The following paragraph
provides a brief summary of the analytic method used for this research, Braun and Clarke’s
(2006) six-step process for conducting thematic analysis.
During the first phase, the researcher became familiar with the data by reading each
transcript twice. On the second reading, initial ideas for coding were noted in the memo
feature of the software program (analogous to writing observations in the margins). The
second phase is where initial codes were generated. The researcher systematically coded the
diversion-related activities of each participant across the entire data set, and collated data
relevant to each code. Once all data had been initially coded and collated, step three began.
This involved sorting the codes into potential themes and gathering all the text data relevant
to each initial theme. Phase four consisted of reviewing and refining the devised set of initial
themes by checking if the data cohered together meaningfully within each theme. Phase five
is where the specifics of each theme were decided upon, and the overall story of the data
emerged, generating clear definitions and names for each theme. In the sixth and final phase,
the report was written, and compelling excerpts from study participants were chosen to
illustrate each theme (Braun & Clarke, 2006). These themes are further discussed in the
following sections.
FINDINGS
General characteristics
The total sample (n = 50) included Black/African-American (n = 15), White/Anglo (n = 20)
and Hispanic/Latino participants (n = 15), ranging in age from 20 to 53 years (mean = 33
years). A total of 36 men and 14 women comprised the final dealer sample. While some
dealers sold only prescription medications (19 of 50), the majority reported having sold both
illicit and prescription drugs (31 of 50). Regarding prescription drug distribution practices,
dealers tended to sell to two general types of customers: individual drug users and other
dealers. Dealers whose customer base consisted of individual users tended to conduct sales
by having their customers meet them in public locations, such as shopping malls, parking
lots or fast food restaurants. These dealers tended to be on the lower end of the profit
spectrum and had to conduct multiple daily transactions in order to sell an entire bottle of
pills. However, some dealers did not sell to individual users, claiming it was both unsafe and
inconvenient. These participants preferred selling to other dealers because they were more
‘business’ minded, less likely to snitch, rarely requested drugs at odd hours, and had more
resources to purchase larger quantities of medications. Participants who dealt their
medications to other dealers typically sold their inventory by the bottle rather than by
individual pills, and conducted sales in other dealers’ homes rather than in public places.
The analysis of dealer interview transcripts revealed six prevalent themes in relation to
diversion: (1) the omnipresence of opioids, (2) pain clinic shopping, (3) sponsorship, (4)
buying scripts, (5) using ‘a connect’, and (6) healthcare fraud. Excerpts from interview
transcripts are presented to help illustrate each theme.
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The omnipresence of opioids
By far, the type of medication most commonly sold by dealers in this sample was
prescription opioid analgesics. Specifically, the highest potency formulations of
Roxicodone® (30 mg) and OxyContin® (80 mg) pills were the opioids with the most
mentions. According to dealers, this was largely due to demand for high potency
medications and their lack of ‘fillers’ such as acetaminophen, ibuprofen or aspirin
commonly found in other pain medications. These ‘fillers’ are undesirable by many abusers
because they can cause allergic reactions, and damage the stomach and liver when taken in
high doses. The opioid of choice was 30 mg Roxicodone pills as this was the medication
most frequently sold by dealers. Participants typically referred to these pills by their street
name, ‘blues’, ‘Roxy’s’ or ‘30’s’. Dealers claimed that there was a particularly high demand
for the ‘blues’ because they provided a ‘nice’ high and were generally cheaper than
OxyContin ($10–$15 per pill vs. $25–$30 per pill). Although OxyContin tended to cost
more, these pills were still highly sought after because they came in the highest available
dose, 80 mg. Percocet® (10 mg) were also in demand, but because these pills contain
acetaminophen, their popularity is diminished some-what. Other type of opioids containing
‘fillers’ such as Vicodin®, Lortab® and Lorcet® were also sold by dealers, but much less
commonly than Roxicodone and OxyContin. Although not an opioid, Xanax® pills (2 mg),
known as ‘zanny bars’ or ‘footballs’, were also a fairly common medication that dealers
reported selling, but this comprised a much lower proportion of their overall sales in
comparison to opioids.
Pain clinic shopping
The most widely utilized source through which dealers obtained prescription drugs was pain
management clinics (26 of 50). Although the majority of the sample reported being free of
chronic pain, visiting numerous pain management clinics for the purpose of obtaining
multiple prescriptions was prevalent. Participants frequently boasted about being able to
easily obtain a prescription for opioids and benzodiazepines by simply complaining of pain
(legitimately or illegitimately) and presenting a magnetic resonance imaging (MRI) report to
a pain doctor. This dealer’s experience was typical:
These pain clinics, they don’t check … you’ll walk back and they’ll be like, ‘Okay,
how’s your back?’ You’ll be like, ‘It hurts’. They’re like, ‘From one to 10 how
much does it hurt?’ ‘Like 10’. They’ll be like, ‘Alright, then we’ll give you 240’. If
you say 5, or a 6 or 7, they’ll give you 160 Oxy’s. So you just go in there and they
just take your word for it … they don’t touch you, they don’t feel your back … You
pretty much just go in with your MRI and walk out with a ’script. (White male, age
26)
Even though most dealers claimed to take an MRI with them to pain clinic visits, it was not
uncommon to hear of instances where prescriptions were written to participants who
furnished the doctor with only a story:
The doctors, they don’t care. Doctors are supposed to want to help people or
whatever, but if somebody like me walks in with no MRI and no nothing, they give
me whatever I ask for. You know? I talk nice, look nice, whatever … I was under
the impression that OxyContin was for the terminally ill and people in a lot of pain
… But I can go and get OxyContin just by complaining about my back, nothing to
back it up. (Hispanic female, age 36)
Other participants described ‘special arrangements’ between themselves and doctors at pain
clinics. In exchange for monthly prescriptions, some participants provided pain management
doctors with additional ‘patients’, sexual favours, illicit drugs and/or ‘under the table’ cash
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payments. This participant would return methadone to the doctor, in exchange for a monthly
prescription of Percocet:
If you can find a doctor that’s, pretty much using his own product, you’re in there
like swimwear … I got a doctor who’s a methadone junky. He can’t write himself a
script. But let’s say you go in and you say, ‘Listen, I need you to write me a script
for 60 Percocets’ … He’ll go ahead on and write me one for 30 methadones, too.
Then I get the Percs, he gets the methadone. (Black female, age 30)
Doctor shopping was the norm among dealers who reported pain clinics as a main diversion
source. On average, participants who used pain clinics as a diversion source visited four to
five clinics every month to stock their inventory of pills. Each visit to the pain clinic, which
could cost anywhere from $100 to $250, almost always resulted in a prescription for both
opioids and benzodiazepines. A typical prescription usually consisted of 160–240 pills of
some form of oxycodone (e.g. Roxicodone, Percocet, OxyContin) and 60–90
benzodiazepine pills (usually Xanax).
I’d go to like 10 pain clinics a month and I’d bring the same MRI to every one. It
was the same thing … I was getting 240 pills from like 10 different doctors. I’d sell
them for 10 dollars apiece. 240 is just what all the pain clinics in South Florida give
… there’s like a chart that they go by and they can give like 240 Roxy blues. And if
they give you that then they can give you 90 Oxy 80s on top of that and 90 Xanax
bars and that was like my normal ‘script. (White male, age 33)
It was not uncommon for participants to be able to get a prescription for two types of pain
medications in the same visit, usually under the banner of ‘break-through’ pain. To the
delight of the following participant, his pain management doctor not only wrote him a
prescription for Roxicodone, but also gave him a prescription for OxyContin in the same
visit:
I’ve had doctors try to give me like 240 blues (Roxicodone). And then give me like
90 Percocet for breakthrough pain … so I started telling them I was allergic to
Tylenol. So once I told them I was allergic to Tylenol they switched the 90
Percocet to 90 OxyContin 80s. (White male, age 26)
Prescriptions were usually filled at smaller family owned pharmacies or dispensed on-site at
the pain clinics. While the on-site pharmacies tended to be slightly more expensive, they
offered the convenience of being able to immediately walk out with the drugs and begin
selling right away. Large chain pharmacies were avoided for fear of being tracked by
computerized databases. This dealer explains how he went about shopping for pain clinics
and pharmacies:
Once a month I got 240 pills. That wasn’t enough because I started selling them
and then the 240 is gone within a couple of days. So then someone tells me to take
my MRI to another doctor … And then I started doctor shopping and I started
selling my scripts … And that’s when I got up to 7 doctors … Going through the
doctors (on-site pharmacy), it costs anywhere from like $1.50 to $4.50 a pill … So,
I go to a mom and pop pharmacy. They’re cheaper and they really don’t ask a lot of
questions. You have to spread it out too. Seven doctors, I need seven different
pharmacies. (White female, age 23)
Sponsorship
Dealers were also able to acquire considerable quantities of prescription drugs by taking part
in a practice known as sponsoring (16 of 50). This consisted of the dealer subsidizing the
cost of someone else’s trip to the pain clinic which included the cost of the visit, the cost to
fill the prescription, transportation costs, and if necessary the cost of an MRI (a one time
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cost of $100–$300 for a counterfeit). In return for sponsorship, the dealer generally required
50–75% of the pills that were prescribed to the sponsored individual (usually a drug abuser).
For their role in the endeavour, the sponsored individual was allowed to keep the remaining
amount of pills, or was simply paid in cash. Lengthy waiting times at pain clinics and
pharmacies often left only enough time for dealers to visit two to three doctors in a given
day. But by sponsoring the visits of others, dealers were able to exponentially increase the
amount of prescription drugs in their inventory, thereby raising profits. This participant
describes the process:
I couldn’t afford to keep going to the doctor, so I’d have to get people to sponsor
me and I’d have to sponsor people just so that I could keep up the pills that I was
using plus make a little bit back so that I could make a next doctor appointment.
When I first started off I was good, I would start off with a couple of people. I
would take two people to the doctor and sponsor them and then get my own script.
So I’d have like 300 pills at all times … I’ll pay for their visit, pay for their drugs,
and then I get half of everything that they get. So if they get 100 Roxy 30’s, 90 of
the (Roxy) 15’s, and 90 Xanax, I’m getting half of all that … which is a pretty good
break. It’s like 500, 600 dollars … You make mad profit off of it. So basically it’s
just sitting there and waiting with them through the doctor visits, I take them to get
their scripts, grab their stuff and we go our separate ways. (White male, age 27)
To obtain as many pills as possible, it was typical for dealers to sponsor others, while still
visiting pain clinics themselves. However, this participant explains why he eventually
stopped visiting pain clinics and opted to just use sponsoring as his sole method of attaining
pills:
Do you know how many doctors I’d have to go to in a week? That’s doctor
shopping. It’s such a serious charge, and it’s easy to detect these days. If I got four
people, that means four times as much and I wouldn’t have to go …. It would be a
lot harder for me to do it by myself. I used to go to like 3 doctors in one day. I used
to go almost every day, but you couldn’t get enough to fill your demand, and to
keep your habit going … You need more than one person to run a habit and still try
to make money. You have to have other people doing it for you. (White male, age
52)
The dealers who reported selling the highest number of pills heavily utilized sponsoring as a
diversion source. In fact, the most voluminous sellers of pills reported developing large
networks of individuals that would visit pain clinics on their behalf. This dealer was able to
garner profits of $40,000 a month by amassing a network of ‘employees’ that exceeded 25
people:
You pack people up in the car and make trips. Most of the time, I’d rent a van. One
trip, I’d take ten, fifteen people down there and they were going to the same clinics.
We’d pile up and they go in there, fill out the paper and they wait. Boom! One at a
time they go on in there. So then we’ll back up and hit the pharmacies. We’d clear
one of them pharmacies out and then the people that still had their paper would go
to another one, clear that one out. The whole time I keep everything written down
because I didn’t want to go to the same doctor with a different script, or the same
prescription place with a different doctor … Some of them have in-house
(pharmacies). If they have in-house, I’d pay extra just to get it over with. A lot of
times we’d buy them out because, if they only get 10,000 pills a day, we were
buying out most of them. (White male, age 29)
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Buying scripts
Some dealers shied away from doctors and pharmacies altogether, and opted to purchase
medications directly from people in their community who were willing to sell (22 of 50).
Dealers tended to seek out individuals with reliable monthly prescriptions for medications,
and who had low or no income, and/or sizable drug habits. Those who most commonly sold
their medications to dealers were veterans, Medicaid/Medicare recipients, crack and heroin
addicts, and HIV/AIDS patients. This participant explains why she preferred to buy the
medications of crack and heroin addicts:
There’s people out there that are crack heads that don’t take their pain medication,
and then sell them to a crack dealer for $20 worth of crack for $50–80 worth of
pills. The drug dealer always knows they’re making out. Down here, Klonopins,
Xanax and Percocet are really big and a lot of people I know have Klonopins and
Percs, and they would give me $100 worth of medicine, and I’d give them $20–30
worth of crack. I straight got over on them. (White female, age 28)
HIV/AIDS patients were also a preferred source for many dealers, primarily because these
patients tended to have regular monthly prescriptions for both opioids and anti-depressants,
with costs usually covered by some form of public assistance program (e.g. Ryan White,
Medicaid, Medicare). While some participants claimed to be approached by HIV/AIDS
patients wanting to sell their medications, most dealers admitted to actively recruiting these
patients because they were such a dependable source for prescription drugs. The following
participant recalled convincing HIV patients to sell him both their sedatives and pain
medications:
We got a lot of AIDS people. They get these things (medications), and they sit on
them because they don’t know what they have, and then I come into your life, and I
go, ‘Oh my God. Are you taking your medicines?’ … they’ve built up all these
medicines.’ I’m like, ‘Damn, you’ve got all these?’ Percocets, Valiums, Xanax …
And remember, they ain’t got no money, so I said, ‘If you want some money right
now then come with me’. (Black male, age 46)
In addition, dealers also bought prescription drugs from veterans who received their
medications through the Veterans Affairs (VA) Hospital. Some dealers preferred buying
medications from veterans because they tended to have prescriptions for stronger, more in
demand medications:
The V.A. That’s my main one is the V.A., ‘cause they get higher and better quality
of prescription drugs than people with the AIDS … They get the real stuff. But the
V.A. is where they get the OxyContin … They get the real more in demand stuff.
So that’s my real hook up right there. I deal with like 15 guys over there. I have for
years. Last month another of my V.A. friends turned me on to another of his friends
who just got in town. (Black male, age 47)
Dealers also tended to purchase the prescription drugs of indigent Medicaid and Medicare
patients. Some dealers claimed that patients receiving Medicaid and Medicare were easy
targets because they were always in need of extra money.
Using a ‘Connect’
Another common method of obtaining prescription drugs was for the dealer to utilize a
‘connect’, short for connection (19 of 50). The term ‘connect’ referred to an individual with
consistent access to prescription medications by working at a healthcare facility (e.g.,
pharmacy, physician/dentist office, or hospital). The role of the ‘connect’ was to provide the
dealer with prescription medication and/or prescription pads (blank or signed by a doctor)
that were stolen from their worksite. This was usually accomplished by systematically
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shorting or undercounting dispensed medications at pharmacies, stealing prescription drug
samples from a dentist or doctor office, tearing off blank prescriptions from the doctor’s
pad, or filing false inventory claims when shipments of prescription drugs came in. By far,
the most commonly utilized connect was a pharmacy technician who was willing to provide
the dealer with prescription drugs via their access as an employee. This participant explains
his partnership with a pharmacy technician who worked in concert with several other
dealers:
I’ve got hook ups from all the way up to all the way down. Oh, the guy I was
telling you about he works in pharmaceuticals … He works in Walgreens, and he’s
the one who gives out the pills when you go and get them. He’s a tech … But he
doesn’t get it for me only. He’s got a couple of customers (other dealers) … I really
don’t know how he does it, and I asked him, ‘Man, how the hell do you come up
with this?’ And he goes, ‘I can’t tell you, man’ … So he didn’t want to tell me, but
I think he’s stealing … Because he’s the boss of all the techs over there … He’s the
one who does inventory and counts everything. (Hispanic male, age 30)
Pharmacy technicians also assisted dealers by not ‘calling in’ or verifying forged
prescriptions, and by providing dealers with ‘inside’ information such as when shipments of
medications were scheduled to come in or details on how to break into the pharmacy
undetected. The following is an example where the pharmacy technician did not actually
steal medications for the dealer, but facilitated diversion by ‘looking the other way’ when a
fraudulent prescription for OxyContin and Xanax was presented:
There was one guy that was in on the Xanax and the Oxy’s thing … Since day one
he knew what was going on. He’s a tech. But he would still fill them. Game
recognize game … I gave him $50 once. And sometimes I would say ‘keep them’
… I would get two or three bottles and have him keep one. He’d just leave them on
the counter. He was just hooking me up. I was hooking him up. He didn’t care
where I was going with them, and I appreciated him looking the other way … You
know when you’re a kid, and the people at McDonald’s might give you some free
fries or biggie size, it’s the same kind of rapport. (Hispanic female, age 28)
Dealers also claimed to have ‘arrangements’ with other types of connects such as pain clinic
employees, dental hygienists, nurses and hospital staff. Although these connects did not
work at traditional pharmacies, they could provide the dealer with access to prescription
drug samples and stolen prescriptions pads. Some pain clinic employees had access to
medications via on-site prescription drug dispensaries. The dealer would typically
compensate the connect in cash, illicit drugs or sometimes sexual favours. The following is
an example of a dealer who provided his connect with marijuana and sex in exchange for
smuggling prescription drugs out of his father’s medical practice where he worked:
His father is a doctor and he’s got some pills, because you know doctors they’ve
got sample pills … So what he does is he steals it from his dad, and then he calls
me. He doesn’t use it. He smokes (marijuana) and shit. He goes, ‘Yo, man, I’ve got
a couple of pills from my dad and stuff,’ and he sells it to me … I buy it from him,
but this is the thing. Since he doesn’t use them, and since he doesn’t sell them, and
since the kid’s got money – his parents got money – all he wants to do is get some
pussy or maybe smoke, so what he says is, ‘Yo, hook me up with a bitch and let me
get a quarter of crip (high grade marijuana), and I’ll give you this bottle.’ That’s
what I did the last time. I gave him a quarter of crip, and he gave me like 100 pills.
So sometimes I trade, and sometimes I buy it from him, but most of the time it’s
trading, because he’s got money. (Hispanic male, age 30)
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Healthcare fraud
Embedded in many of the participants’ diversion behaviours were various types of
fraudulent activity. Among the most common types of fraud committed were MRI fraud,
prescription fraud and fraud related to Medicare, Medicaid and other types of medical
insurance. With MRI fraud, dealers reported obtaining counterfeit or forged MRIs to present
to doctors as they attempted to pain clinic shop and sponsor the visits of others. This was
done to avoid the cost of obtaining a legitimate MRI, which can cost upward of $1000 for a
single scan. Some participants created counterfeit MRI’s using computer software programs
such as Microsoft Word, Quark and Adobe Photoshop, others simply put their name on
someone else’s to make it appear as if it was theirs.
One of my girlfriend’s mom was in a car accident and she has a good MRI, so I
copied hers and I re-typed my MRI … she has serious back problems, like serious
… So, I re-typed her report with my name on my computer and scanned it in. Copy,
paste, cut, re-type, put my name. Oh, it looked good. A lot of people do that. Some
people will even sell you their MRI, and you just re-do it. (White female, 23)
Instead of creating their own MRIs, some dealers purchased them through rogue employees
at MRI centres or on the street:
Usually you have to know somebody that works at the MRI place or you can get
somebody who knows a little bit about computers and have them do your MRI
report which is usually like 200 bucks for an MRI report. (White male, age 27)
Prescription fraud was also prevalent, with many of our participants obtaining stolen
prescription pads from connects and presenting them at pharmacies. Additionally, fraud
related to Medicare, Medicaid and other types of health insurance providers were committed
by participants in their efforts to obtain prescription drugs. While the majority of dealers
reported making sizable profits from selling prescription drugs, the cost of obtaining pills
was also quite substantial. By fraudulently billing these insurance providers for doctor visits
and the filling of prescriptions, some dealers were able to offset their upfront costs, and
effectively boost profits. This dealer forged prescriptions, and then billed his father’s
publicly funded insurance provider to cover the cost of OxyContin pills that he would later
sell for profit:
The thing I was scared of was that I stole some prescription pads from the
emergency room, and that scared me. I put them in my dad’s name. My dad’s in the
military, so all his prescriptions are three dollars, no matter what they are. I was
scared of that, especially for writing prescriptions for Oxys from the emergency
room. It was scary, but nobody caught on. I’m still scared. You never know when
they’re going to catch on. (Hispanic female, age 36)
DISCUSSION
Empirical data on prescription drug diversion are quite limited in the scientific literature.
Although a number of studies have documented prescription drug abuse and diversion
among health care professionals (Hollinger & Dabney, 2002; Inciardi, Surratt, Kurtz, &
Burke, 2006; Trinkoff, Storr, & Wall, 1999; Trinkoff, Zhou, Storr, & Soeken, 2000; Weir,
2000), there are few published reports that explain how vast quantities of abused
prescription drugs are reaching the streets, or comprehensively examine particular
mechanisms of diversion. Recent data collected from a variety of prescription drug abuser
samples suggest that dealers are a primary source for illicitly obtaining prescription drugs,
reaching 70–80% among street drug users, treatment clients and methadone maintenance
patients (Cicero et al., 2011; Inciardi et al., 2010). Nevertheless, additional data on this
phenomenon are generally unavailable – primarily because dealers are a difficult population
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to access. To our knowledge, this study provides the first empirical data to elucidate the role
of dealers in channeling prescription drugs from the licit to illicit market. Figure 1
summarizes the major diversion mechanisms of the dealers who were interviewed for this
study.
The data presented in this study indicate that pain management clinics are a major diversion
source for dealers. This is consistent with the findings of previous research that also found
evidence of abusers/diverters visiting pain clinics to acquire prescription opioids and
sedatives (Cicero & Inciardi, 2005; Inciardi, Surratt, Lugo, et al., 2007; Rigg, March, &
Inciardi, 2010). These findings lend support to the creation of Florida’s proposed
prescription drug monitoring program (PMP), which should increase the ability of law
enforcement and healthcare officials to detect and deter doctor shopping (Edwards, 2010).
The data presented here suggest that a PMP will have a meaningful impact on reducing the
amount of prescription drugs that end up in the hands of dealers, and ultimately abusers. The
original PMP start date of 1 December 2010 has been delayed due to a lack of funding to
cover ‘start up costs’ and a well-publicized contractual dispute over the hiring process of the
company that was secured to launch the program. Although Florida Governor, Rick Scott,
remains publicly opposed to the PMP citing infringements on patient privacy, its creation
appears imminent. As of this writing, the Florida Department of Health has given November
2011 as a tentative start date for the PMP (LaMendola, 2011). Until then, Florida remains
the largest state without such a program.
Healthcare fraud, namely Medicare/Medicaid fraud, is a national problem that can increase
taxes, the cost of medical care and insurance rates. According to recent numbers, South
Florida easily ranks number one when it comes to healthcare fraud in the USA, leading the
US Attorney’s Office to select Miami to launch its first task force to fight Medicare fraud
(Burnside, 2010). To date, this task force has indicted 860 people in 567 cases involving
$2.5 billion in Medicare fraud in South Florida alone (Burnside, 2010). The evidence
uncovered in this study indicates that there is a connection between the prescription drug
diversion problem and the issue of healthcare fraud by revealing healthcare fraud to be a
major source of diversion. Efforts to curb healthcare fraud such as the federal taskforce
described above should concomitantly combat the prescription drug diversion/abuse
problems by targeting an important diversion source for dealers. The study results support
the funding of fraud reduction initiatives, as it implies that for every dollar spent combating
healthcare fraud, a portion will also go towards reducing diversion. Finally, our findings also
highlight the need to further investigate other types of healthcare fraud such as MRI and
prescription fraud as these too appear to play a central role in connecting dealers to their
illicit supplies of prescription drugs.
Our finding that ‘connects’ in healthcare settings are playing a key role in facilitating
diversion is a serious concern. This may reflect a need for increased training and supervision
for healthcare workers who directly (or indirectly) have access to controlled medications,
namely those who work in pharmacies, pain management clinics and dentist offices.
Pharmacy techs were the ‘connect’ with the most mentions, indicating that they play a more
prominent role vis-à-vis other connects. Based on this, there is a need to expand the
diversion component of education/training curriculum and certification standards for
pharmacy employees with access to controlled medications such as pharmacy techs. It is
important to note that this is consistent with recent recommendations from the National
Association of Boards of Pharmacy, who have also documented substantial diversion-related
activities among pharmacy technicians (Thompson, 2006; Traynor, 2003).
We also found evidence that patients are illegally selling their medications to dealers,
particularly those with crack/heroin habits, HIV patients, Medicare/Medicaid recipients and
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veterans. Patient education might also be considered in the areas of safeguarding
medications, and understanding the consequences of selling their medications and deceiving
physicians and pharmacists (Inciardi et al., 2009a). This should also help to deter the
practice of sponsoring, a heavily relied upon diversion mechanism. Indigent, illicit-drug
using patients who are consistently prescribed opioids appear to be at higher risk of selling
their medications to dealers and/or agreeing to be sponsored by one. Additionally, our
findings also suggest that compared to other classes of prescription medications, opioids are
most prominent across the diversion landscape in South Florida and likely elsewhere. This is
consistent with other research that also found opioids to be popular in street markets
(Inciardi, Surratt, Lugo, et al., 2007; Inciardi, Surratt, Kurtz, et al., 2007; Rigg & Ibañez,
2010). The data presented here indicate that efforts at curbing opioid diversion are
inadequate and should not only be intensified, but specifically target ‘filler’ free opioids
such as OxyContin (80 mg) and Roxicodone (30 mg) which appear to be in higher demand
among abusers.
Study limitations and strengths
Our findings should be interpreted within the context of the study limitations. First, it should
be noted that we were unable to recruit large scale dealers, and the data presented here likely
do not characterize the diversion activities of the most prolific dealers. Second, because
face-to-face interviewing was utilized as a means of data collection, interviewer bias may
have been a possibility. The inherent limitations of self-report data (e.g. recall bias) also
apply to this research. Finally, because this research was conducted in South Florida, a high
incidence area for prescription drug abuse/diversion, the authors recognize that the data
presented here may not be representative of all drug dealers across the USA; however it is
reasonable to assume that South Florida’s diversion landscape is similar to that of other
metropolitan areas, even if somewhat more robust.
The study also contained some noteworthy strengths. The authors utilized qualitative
methods of data collection and analysis, an approach most felicitous for exploring complex
processes and ‘hidden’ phenomenon such as diversion. In particular, the use of in-depth
interviewing and inductive analytic methods allowed for new themes to emerge so that a
more comprehensive understanding of these previously unexplored aspects of diversion
could be achieved. Another major strength of this study is that we were able to access a
‘hard to reach’ population that is not well understood or researched in terms of its diversion
activities. The sample size (n = 50) is also larger than most qualitative studies, which
reduced the chance of discovery failure (DePaulo, 2000) and enhanced our ability to
determine that data redundancy/saturation was achieved (Sandelowski, 1995).
Conclusion
Overall, our data on the diversion activities of dealers are important to consider within the
context of prevention and intervention strategies for addressing the national epidemic of
prescription drug abuse. As this study has documented, a substantial proportion of the illegal
channeling of prescription opioids through dealers originates in health care sources (pain
clinics, sponsoring, ‘connects’ in pharmacies and health care facilities). This would indicate
that legislative and health care systems-level interventions may be highly effective in
reducing the availability of prescription drugs through dealers, who clearly serve as a critical
access point for a large number of abusers. These data should serve as a guide for making
regulatory decisions and for developing educational initiatives for patients, prescribers and
dispensers of scheduled medications. It should also inform the creation of future prescription
drug diversion and abuse prevention programs.
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Figure 1.
Diagram of diversion sources utilized by dealers.
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